Auto Fecal Microbial Transplant Post Helicobacter Pylori Antibiotic Therapy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Auto Fecal Microbial Transplant Post Helicobacter Pylori Antibiotic Therapy — Stella

Home/Helicobacter Pylori Infection/

View on ClinicalTrials.gov

Recruiting

Back to Helicobacter Pylori Infection trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Israel

Dep. of Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv

Key details

Phase

Early testing / Safety & dosing

Sponsor

Tel-Aviv Sourasky Medical Center

Collaborators

Weizmann Institute of Science

Enrollment target

~30 participants

Started

September 2018

Primary completion

July 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

Age range

18 Years – 70 Years

Last updated July 2024